Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fudan University
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed content obtained prior to treatment
Age ≥ 18 years and ≤ 80 years
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
Patients must have histologically confirmed pancreatic adenocarcinoma
History of diabetes mellitus, or newly diagnosed diabetes mellitus according to the American Diabetes Association criteria
The expected survival after surgery ≥ 3 months
You may not be if
Active second primary malignancy or history of second primary malignancy
Patients who have received any form of anti-tumor therapy including surgery, chemotherapy, radiotherapy, interventional chemoembolization, radiofrequency ablation, and molecular targeted therapy
Inflammation of the digestive tract, including pancreatitis, cholecystitis, cholangitis, etc
Pregnant or nursing women
Patients who are unwilling or unable to comply with study procedures
